BIOMERIEUX (EPA:BIM) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
BIOMERIEUX

BRIEF

published on 11/06/2024 at 09:59, 15 days 1 hour ago

Status of bioMérieux Shares and Voting Rights for October 2024

Voting Rights BioMérieux Actions Financial Regulation October 2024
BRIEF

published on 10/30/2024 at 07:06, 22 days 3 hours ago

BioMérieux Reports Solid Third-Quarter Performance in 2024

Financial Performance Diagnostic Solutions Sales Growth BioMérieux 2024 GO•28 Strategy
REGULATED PRESS RELEASE

published on 10/30/2024 at 07:01, 22 days 3 hours ago

bioMérieux – Third-Quarter 2024 Business Review
bioMérieux reports strong +10.3% organic sales growth, reaching €2,871m in the first nine months of 2024, driven by growth drivers like GO•28 strategic plan and BIOFIRE® respiratory panels. Q3 2024 shows an +11% organic sales growth with confirmation of 2024 full-year revised guidance. CEO Pierre Boulud expresses confidence in achieving targets

BioMérieux Organic Sales Growth 2024 Guidance GO•28 Strategic Plan BIOFIRE Respiratory Panels
BRIEF

published on 10/15/2024 at 07:06, 1 month 6 days ago

BioMérieux Receives CE-Marking for VIDAS® Vitamin B12 Test

BioMérieux Diagnostics Vitamin B12 CE-marking VIDAS®
REGULATED PRESS RELEASE

published on 10/15/2024 at 07:01, 1 month 6 days ago

bioMérieux receives CE-marking for VIDAS® VITAMIN B12 TOTAL, a blood test to measure total Vitamin B12 concentration
bioMerieux announces CE-marking for VIDAS Vitamin B12 Total, an automated blood test to measure total B12 concentration in serum or plasma, aiding in the assessment of B12 status and optimizing patient care

BioMérieux CE-marking VIDAS Vitamin B12 Total Blood Test
BRIEF

published on 10/08/2024 at 10:45, 1 month 13 days ago

Update of the number of shares and voting rights of bioMérieux

Voting Rights BioMérieux Actions Transparency Financial Market
REGULATED PRESS RELEASE

published on 09/05/2024 at 07:01, 2 months 16 days ago

bioMérieux – First-Half 2024 Results
BRIEF

published on 08/06/2024 at 17:39, 3 months 14 days ago

BioMérieux statement on voting rights in July 2024

Voting Rights BioMérieux Actions AMF Financial Informations
BRIEF

published on 07/05/2024 at 15:57, 4 months 15 days ago

BioMérieux: Information on the number of shares and voting rights in June 2024

Share Capital Voting Rights BioMérieux Actions June 2024
BRIEF

published on 06/26/2024 at 07:06, 4 months 25 days ago

BioMérieux Receives FDA Clearance and CLIA-Waiver for BIOFIRE® SPOTFIRE® R/ST Panel Mini

BioMérieux FDA Clearance BIOFIRE® SPOTFIRE® CLIA-waiver PCR Test

1 2 ... 4

Accesswire

Published on 11/21/2024 at 10:03, 57 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 25 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 35 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:56, 3 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 30 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 55 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 58 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 1 hour ago

Nabaltec AG continues solid earnings performance in third quarter of 2024

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 2 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 40 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 15 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 15 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE